YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Chemoresponse Assays Help Clinicians Determine Treatment



August 22, 2013 | Researchers evaluated the effectiveness of the ChemoFx assay by testing patients’ tumor samples for sensitivity and resistance to various chemotherapeutic agents. Patients treated with a sensitive regimen showed significant improvement in overall survival and progression-free survival. With promising results, researchers are convinced diagnostic testing could help clinicians individualize therapy in a tumor type where there are many equivalent treatment options. OncLive
Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.